-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Resomelagon in Inflammatory Bowel Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Inflammatory Bowel Disease Drug Details: Resomelagon is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Unesbulin in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in High-Grade Glioma Drug Details: Unesbulin (PTC-596) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Adenocarcinoma Drug Details: Unesbulin (PTC-596) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zinpentraxin Alfa in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Zinpentraxin Alfa in Crohn's Disease (Regional Enteritis) Drug Details:Zinpentraxin alfa (PRM-151) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Solid Tumor Drug Details: Unesbulin (PTC-596) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Glioblastoma Multiforme (GBM) Drug Details: Unesbulin (PTC-596) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Anaplastic Astrocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Anaplastic Astrocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Anaplastic Astrocytoma Drug Details: Unesbulin (PTC-596) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Pediatric Diffuse Intrinsic Pontine Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Pediatric Diffuse Intrinsic Pontine Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Pediatric Diffuse Intrinsic Pontine Glioma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GEM-103 in Geographic Atrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GEM-103 in Geographic Atrophy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GEM-103 in Geographic AtrophyDrug Details:GEM-103 is under development for the treatment of geographic...